chief scientific officer
Tim Mayleben Named President And CEO Of Esperion Therapeutics
Esperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, announced that Tim Mayleben has been named president and CEO of the company.
HR Notices From October 17
The latest staffing and boardroom news from Michigan’s technology-focused companies and institutions


















